Analysis
Sutro Biopharma 2025 Financial Review
Sutro Biopharma is a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs). For the year...
ADVERTISEMENT
Analysis
Expert equity analysis, earnings previews, and data-driven market research.
Latest Research
2,307 articles
Analysis
Talphera Q4 and Full Year 2025 Financial Update
Talphera is a specialty pharmaceutical company developing therapies for medically supervised settings. They are currently advancing their lead...
Analysis
Context Therapeutics 2025 Financial Review
Context Therapeutics is a clinical-stage biopharmaceutical company developing T cell engaging bispecific antibodies for solid tumors. The company...
Analysis
Lithium Argentina 2025 Financial Review
Lithium Argentina produces lithium carbonate primarily for the electric vehicle and battery markets. The company operates and holds...
Analysis
AGI Q4 FY25 Earnings Results
AGI is a profitable fintech providing financial services to underserved Brazilians. It operates a hybrid business model combining...
Analysis
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review
March 20, 2026 — NVIDIA is positioning for a return to China’s AI accelerator market after the U.S....
Analysis
Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92
March 20, 2026 — Qualcomm’s board approved a new $20 billion stock repurchase authorization and raised its quarterly...
Analysis
Xunlei (XNET) Q4 Earnings: Adjusted EPS Declines YoY to $0.08; Revenue Jupms 70%
Xunlei's Q4 adjusted EPS of $0.08 matched the prior quarter as revenue stalled at $143.3M, raising concerns about...
Analysis
Li Auto (LI) Q4 Earnings Beat by 15.2% Despite Revenue Plunging 90.7% YoY to $4.1B
Li Auto Q4 adjusted EPS of $0.25 beat by 15%, but revenue collapsed 91% YoY to $4.1B as...
Analysis
Full Truck Alliance (YMM) Q4 Revenue Crashes 85.6% to $456.5M Despite Meeting EPS Estimates
Full Truck Alliance Q4 EPS of $0.14 matched estimates but revenue plunged 86% year-over-year to $456.5M, capping a...
Analysis
Xunlei (XNET) Posts $0.08 EPS on $143.3M Revenue, But $228.9M GAAP Loss Sparks Concern
Xunlei's Q4 adjusted EPS of $0.08 matched the prior quarter on flat $143.3M revenue, while a $228.9M GAAP...
Analysis
Gambling.com (GAMB) Q4 Revenue Surges 30.9% to $46.2M, But EPS Plunges 320% on Margin Compression
Gambling.com's Q4 adjusted EPS of $0.30 held flat sequentially despite 31% revenue growth, snapping a three-quarter beat streak...